Physician profile
William Martin
NPI 1700896131
$951.81
in general payments reported to CMS, 2019-2025
8 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2024: $507 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $337.83 | 2024-2025 | Phasix Mesh |
| Smith+Nephew, INC. | $172.74 | 2024 | Grafix, Oasis, Grafix Pl |
| Aesculap Implant Systems, LLC | $147.24 | 2022 | |
| Acera Surgical, INC. | $121.49 | 2024 | Restrata Wound Matrix |
| Organogenesis INC. | $101.71 | 2024-2025 | Apligraf |
| Integra Lifesciences Corporation | $37.05 | 2022 | |
| Solventum Corporation | $19.24 | 2024 | Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $14.51 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.